Evidence suggests the gene NFKB could be a genetic pathway for amplifying inflammation in sepsis, a leading cause of hospital deaths.
Researchers used blood from human subjects and found patients with a specific genetic variation had an increase in the gene after infection. The study could determine if anti-inflammatory sepsis treatment should be tailored for patients with certain genetic sequences.
More Articles on Anesthesia:
What Does the Future Hold for Ambulatory Anesthesia? Q&A With SAMBA’s Dr. Michael Walsh
CMS Braces for 27% Mandated Sustainable Growth Rate Cut in 2013
Proposed Legislation Could Ease Anesthesia Participation in Meaningful Use
